should get an information full update this week. not sure about a deal (YET)
- prototype development for ev1, marquee European ev company
- ev2, development program to incorporate our silicon anode tech. sounds a bit like a jv development
- giga factory project running in parallel with the above 2
- consumer electronics 1 & 2, been running for over 3 mths with expected 6 mth testing program
- advancement and program structure with 3 more ev companies and 3 more battery manufacturers
- SIOI progression "SII are the world’s leading vaccine manufacturer and are currently using AnteoBind in the development of a new vaccine. The incorporation of AnteoBind into a vaccine manufacturing process, if approved by international regulatory bodies, would ensure AnteoBind would be used for the life of the vaccine which is typically more than 20-years, providing a long-term annuity-style revenue stream for AnteoTech. The discussions for an initial commercial contract are well advanced."
if anteobind was only used for quality control testing why is it involved in the manufacturing process and needs regulatory approval?
- anteobind NXT launch. "A leading international in vitro diagnostics (IVD) manufacturer has successfully leveraged AnteoBind NXT to develop assays that are not compatible with EDC/sNHS."
already have a published paper of a development and validation of a RSV multiplex immunoassay that shows huge improvements in performance.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)